|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02329 GLORY HEALTH
Nominal 
0.108 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 679,533 | 512,922 | 606,314 | 4,345,276 | 4,938,208 |
| Net Cash from / (used in) Investing Activities | 146,718 | 58,955 | (305,414) | 184,152 | (2,777,652) |
| Net Cash from / (used in) Financing Activities | (830,497) | (627,400) | (630,905) | (5,654,153) | (1,112,532) |
| Increase / (Decrease) in Cash & Cash Equivalents | (4,246) | (55,523) | (330,005) | (1,124,725) | 1,048,024 |
| Cash & Cash Equivalents at beginning of period | 74,697 | 130,220 | 460,225 | 1,584,950 | 536,926 |
| Effect of Foreign Exchange Rate Changes | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 70,451 | 74,697 | 130,220 | 460,225 | 1,584,950 |
| Remarks: | Real time quote last updated: 12/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -225,179 |
| %Change | 283.878% |
| EPS / (LPS) | RMB -0.051 |
| NBV Per Share (¥) | RMB 2.183 |